ArticleFrontiers in oncology2022

Efficacy and Safety of Low-Dose Nab-Paclitaxel Plus Tislelizumab in Elderly Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer.

Wenyu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.